143 related articles for article (PubMed ID: 16839340)
1. Slice me nice: DNAzymes get close to the heart.
Kelley R; Patterson C
J Thromb Haemost; 2006 Jul; 4(7):1476-8. PubMed ID: 16839340
[No Abstract] [Full Text] [Related]
2. DNAzymes as potential therapeutic molecules.
Isaka Y
Curr Opin Mol Ther; 2007 Apr; 9(2):132-6. PubMed ID: 17458166
[TBL] [Abstract][Full Text] [Related]
3. DNAzymes and their therapeutic possibilities.
Chan CW; Khachigian LM
Intern Med J; 2009 Apr; 39(4):249-51. PubMed ID: 19402864
[TBL] [Abstract][Full Text] [Related]
4. DNAzyme loaded nano-niosomes attenuate myocardial ischemia/reperfusion injury by targeting apoptosis, inflammation in a NF-κB dependent mechanism.
Naseroleslami M; Mousavi Niri N; Hosseinian SB; Aboutaleb N
Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):2127-2136. PubMed ID: 36941384
[TBL] [Abstract][Full Text] [Related]
5. DNAzymes targeting the transcription factor Egr-1 reduce myocardial infarct size following ischemia-reperfusion in rats.
Bhindi R; Khachigian LM; Lowe HC
J Thromb Haemost; 2006 Jul; 4(7):1479-83. PubMed ID: 16839341
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of the master regulator transcription factor Egr-1 with catalytic oligonucleotides reduces myocardial injury and improves left ventricular systolic function in a preclinical model of myocardial infarction.
Rayner BS; Figtree GA; Sabaretnam T; Shang P; Mazhar J; Weaver JC; Lay WN; Witting PK; Hunyor SN; Grieve SM; Khachigian LM; Bhindi R
J Am Heart Assoc; 2013 Jul; 2(4):e000023. PubMed ID: 23902638
[TBL] [Abstract][Full Text] [Related]
7. Propofol improves cardiac functional recovery after ischemia-reperfusion by upregulating nitric oxide synthase activity in the isolated rat hearts.
Sun HY; Xue FS; Xu YC; Li CW; Xiong J; Liao X; Zhang YM
Chin Med J (Engl); 2009 Dec; 122(24):3048-54. PubMed ID: 20137500
[TBL] [Abstract][Full Text] [Related]
8. DNAzymes: cutting a path to a new class of therapeutics.
Khachigian LM
Curr Opin Mol Ther; 2002 Apr; 4(2):119-21. PubMed ID: 12044032
[TBL] [Abstract][Full Text] [Related]
9. DNAzyme-based therapeutics for cancer treatment.
Fu S; Sun LQ
Future Med Chem; 2015; 7(13):1701-7. PubMed ID: 26381244
[TBL] [Abstract][Full Text] [Related]
10. Antisense applications for biological control.
Pan WH; Clawson GA
J Cell Biochem; 2006 May; 98(1):14-35. PubMed ID: 16440307
[TBL] [Abstract][Full Text] [Related]
11. Resurrecting DNAzymes as sequence-specific therapeutics.
Rossi JJ
Sci Transl Med; 2012 Jun; 4(139):139fs20. PubMed ID: 22723461
[TBL] [Abstract][Full Text] [Related]
12. [Coenzyme Q10 single intravenous infusion protects rat myocardium against subsequent ischemia/reperfusion].
Ivanov AV; Gorodetskaia EA; Kalenikova EI; Medvedev OS
Eksp Klin Farmakol; 2013; 76(2):6-8. PubMed ID: 23631275
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1.
Chen H; Li D; Saldeen T; Mehta JL
Am J Physiol Heart Circ Physiol; 2003 May; 284(5):H1612-7. PubMed ID: 12679326
[TBL] [Abstract][Full Text] [Related]
14. Long-term infusion of Met5-enkephalin fails to protect murine hearts against ischemia-reperfusion injury.
Kuzume K; Kuzume K; Cao Z; Liu L; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1717-23. PubMed ID: 15550529
[TBL] [Abstract][Full Text] [Related]
15. Applications of nucleic acid technology in the CNS.
Trülzsch B; Wood M
J Neurochem; 2004 Jan; 88(2):257-65. PubMed ID: 14690514
[TBL] [Abstract][Full Text] [Related]
16. Ribozymes, DNAzymes and small interfering RNAs as therapeutics.
Sioud M; Iversen PO
Curr Drug Targets; 2005 Sep; 6(6):647-53. PubMed ID: 16178798
[TBL] [Abstract][Full Text] [Related]
17. Effect of isoflurane on myocardial ischemia-reperfusion injury through the p38 MAPK signaling pathway.
Zhou Y; Peng DD; Chong H; Zheng SQ; Zhu F; Wang G
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1342-1349. PubMed ID: 30779102
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of semicarbazide-sensitive amine oxidase attenuates myocardial ischemia-reperfusion injury in an in vivo rat model.
Yang W; Li H; Luo H; Luo W
Life Sci; 2011 Feb; 88(7-8):302-6. PubMed ID: 21146547
[TBL] [Abstract][Full Text] [Related]
19. DNA enzymes as potential therapeutics: towards clinical application of 10-23 DNAzymes.
Fokina AA; Stetsenko DA; François JC
Expert Opin Biol Ther; 2015 May; 15(5):689-711. PubMed ID: 25772532
[TBL] [Abstract][Full Text] [Related]
20. c-Jun DNAzymes inhibit myocardial inflammation, ROS generation, infarct size, and improve cardiac function after ischemia-reperfusion injury.
Luo X; Cai H; Ni J; Bhindi R; Lowe HC; Chesterman CN; Khachigian LM
Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1836-42. PubMed ID: 19592465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
